Joel D. Morrisett

Joel D. Morrisett's AcademicInfluence.com Rankings

Joel D. Morrisett

Medical

#3252

World Rank

#3714

Historical Rank

Pharmacology

#398

World Rank

#451

Historical Rank

medical Degrees

Download Badge

Medical

Joel D. Morrisett's Degrees

PhD Pharmacology University of California, San Francisco
Bachelors Biochemistry University of California, Davis

Why Is Joel D. Morrisett Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joel D. Morrisett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins (1990) (888)
A molecular theory of lipid—protein interactions in the plasma lipoproteins (1974) (582)
Human plasma lipoprotein [a]. Structural properties. (1983) (421)
Lipoprotein structure and metabolism. (1976) (296)
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. (1973) (274)
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients DOI 10.1194/jlr.M100392-JLR200 (2002) (265)
Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. (1990) (263)
Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. (1989) (255)
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. (2001) (232)
Lipid-protein interactions in the plasma lipoproteins. (1977) (230)
Preservation of Endothelium, Dependent Vascular Relaxation in Cholesterol, Fed Rabbit by Treatment with the Calcium Blocker PN 200110 (1986) (228)
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. (1993) (214)
Lipoproteins: structure and function. (1975) (209)
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. (1982) (188)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects: The Atherosclerosis Risk in Communities (ARIC) Study (2011) (185)
The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women. (1993) (154)
Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women (1991) (144)
Lipoprotein[a] as a risk factor for preclinical atherosclerosis. (1993) (144)
Isolation and characterization of the two major apoproteins in human lipoprotein [a]. (1987) (126)
Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients. (2001) (123)
Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. (2005) (120)
Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study (2006) (117)
Multiple thermotropic phase transitions in Escherichia coli membranes and membrane lipids. A comparison of results obtained by nitroxyl stearate paramagnetic resonance, pyrene excimer fluorescence, and enzyme activity measurements. (1975) (105)
Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. (1996) (104)
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. (2001) (104)
A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. (1989) (98)
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. (2003) (97)
Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy Tissues (2006) (96)
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation Published, JLR Papers in Press, August 16, 2004. DOI 10.1194/jlr.M400229-JLR200 (2004) (95)
A convenient synthesis of phosphatidylcholines: acylation of sn-glycero-3-phosphocholine with fatty acid anhydride and 4-pyrrolidinopyridine. (1979) (94)
Spin-label-induced nuclear relaxation. Distances between bound saccharides, histidine-15, and tryptophan-123 on lysozyme in solution. (1972) (92)
The role of dietary polyunsaturated fat in lowering blood cholesterol in man. (1978) (91)
Bovine serum albumin. Study of the fatty acid and steroid binding sites using spin-labeled lipids. (1975) (89)
The primary structure of apolopoprotein-serine. (1974) (86)
Quantitation, isolation, and characterization of human lipoprotein (a). (1986) (83)
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. (1992) (81)
Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). (1995) (81)
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients. (2003) (80)
The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. (1993) (78)
Discrimination of components in atherosclerotic plaques from human carotid endarterectomy specimens by magnetic resonance imaging ex vivo. (2003) (76)
Differential proteoglycan and hyaluronan distribution in calcified aortic valves. (2011) (74)
Interactions of myristic acid with bovine serum albumin: a 13C NMR study. (1984) (74)
A structural assessment of the apo[a] protein of human lipoprotein[a] (1992) (73)
Influence of short term dietary cholesterol and fat on human plasma Lp[a] and LDL levels. (1991) (68)
Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3. (1977) (64)
Bilateral Symmetry of Human Carotid Artery Atherosclerosis (2002) (61)
Genetic Susceptibility and Resistance to Diet‐induced Atherosclerosis and Hyperlipoproteinemia (1982) (61)
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. (2004) (61)
Chapter 4 Lipoprotein(a): structure, metabolism and epidemiology (1987) (60)
Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E (1994) (59)
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. (1993) (59)
Detection of hydroxyapatite in calcified cardiovascular tissues. (2012) (58)
Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a]. (1993) (58)
The interaction of apolipoprotein-serine with phosphatidylcholine. (1974) (58)
Structure and metabolism of lipoprotein (a) (1995) (54)
Human high density lipoprotein, apolipoprotein glutamine II. The immunochemical and lipid-binding properties of apolipoprotein glutamine II derivatives. (1973) (54)
Structure of the dimyristoylphosphatidylcholine vesicle and the complex formed by its interaction with apolipoprotein C-III: X-ray small-angle scattering studies. (1979) (53)
Quantification of calcification in atherosclerotic lesions. (2005) (50)
Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studies. (1973) (49)
Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells. (2010) (48)
Oxidation of the sulfhydryl and disulfide groups by the nitroxyl radical. (1969) (48)
The requirement for lipid fluidity in the formation and structure of lipoproteins: thermotropic analysis of apolipoprotein-alanine binding to dimyristoyl phosphatidylcholine. (1974) (47)
Quantification in situ of crystalline cholesterol and calcium phosphate hydroxyapatite in human atherosclerotic plaques by solid-state magic angle spinning NMR. (2000) (46)
Physical properties of the dimyristoylphosphatidylcholine vesicle and of complexes formed by its interaction with apolipoprotein C-III. (1977) (45)
Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a]. (1993) (45)
Effect of saturated and unsaturated fat diets on molecular species of phosphatidylcholine and sphingomyelin of human plasma lipoproteins. (1981) (44)
Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[S] (2009) (43)
Nuclear magnetic resonance studies of lipoproteins. (1986) (42)
Influence of dietary trans-fatty acids on swine lipoprotein composition and structure. (1977) (41)
8 – The Use of Spin Labels for Studying the Structure and Function of Enzymes (1976) (40)
The role of lipoprotein[a] in atherosclerosis (2000) (40)
Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy. (1996) (40)
Chemical synthesis and biochemical properties of peptide fragments of apolipoprotein-alanine. (1973) (40)
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. (1991) (40)
Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. (2001) (38)
Active site spin-labeled -chymotrypsin. Guanidine hydrochloride denaturation studies using electron paramagnetic resonance and circular dichroism. (1971) (38)
Structure of the major complex formed by interaction of phosphatidylcholine bilamellar vesicles and apolipoprotein-alanine (APO-C-III). (1974) (38)
Dietary cholesterol absorption, and sterol and bile acid excretion in hypercholesterolemia-resistant white rabbits. (1990) (38)
Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits. (1989) (36)
Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). (1994) (36)
Effect on saturated and unsaturated fat diets on lipid profiles of plasma lipoproteins. (1982) (35)
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians. (2008) (34)
Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm (1997) (34)
Fluorine-, pyrene-, and nitroxide-labeled sphingomyelin: semi-synthesis and thermotropic properties. (1985) (34)
High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance. (2013) (34)
Structure of an apolipoprotein-phospholipid complex: apoC-III induced changes in the physical properties of dimyristoylphosphatidylcholine. (1976) (33)
A comparative study of spin-labeled serine enzymes: acetylcholinesterase, trypsin, -chymotrypsin, elastase, and subtilisin. (1972) (33)
Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. (1992) (31)
A new spin label specific for the active site of serine enzymes. (1969) (29)
Chapter 4 – Structural Properties of Apo(a): A Major Apoprotein of Human Lipoprotein(a) (1990) (29)
Selective oxidation in vitro by myeloperoxidase of the N-terminal amine in apolipoprotein B-100. (2001) (29)
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma. (1989) (28)
Binding of the chemical carcinogen, p‐dimethylaminoazobenzene, by human plasma low density lipoproteins (1979) (28)
Quantification of Cholesteryl Esters in Human and Rabbit Atherosclerotic Plaques by Magic-Angle Spinning 13C-NMR (2000) (27)
Distribution of Alkaline Phosphatase, Osteopontin, RANK Ligand and Osteoprotegerin in Calcified Human Carotid Atheroma (2015) (27)
Hormonal agents used in lowering lipoprotein(a). (1994) (27)
Feasibility of in vivo, multicontrast‐weighted MR imaging of carotid atherosclerosis for multicenter studies (2005) (27)
Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. (2011) (26)
Triglyceride metabolism in 3T3-L1 cells. An in vivo 13C NMR study. (1992) (26)
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. (1996) (25)
Thermotropic properties and molecular dynamics of cholesteryl ester rich very low density lipoproteins: effect of hydrophobic core on polar surface. (1984) (25)
Application of protein lysate microarrays to molecular marker verification and quantification (2005) (25)
Effect of particle size and temperature on the conformation and physiological behavior of apolipoprotein E bound to model lipoprotein particles. (1990) (25)
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). (2013) (24)
Apolipoprotein A-II: chemical synthesis and biophysical properties of three peptides corresponding to fragments in the amino-terminal half. (1979) (23)
Comparison of 15 different stents in superficial femoral arteries by high resolution MRI ex vivo and in vivo (2005) (22)
Rapid identification of common human pathogens by high-resolution proton magnetic resonance spectroscopy (1995) (22)
Peripheral Arterial Occlusive Disease: Magnetic Resonance Imaging and the Role of Aggressive Medical Management (2007) (22)
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. (2011) (21)
Effect of temperature on permeation of low‐density lipoprotein particles through human carotid artery tissues (2009) (21)
Microemulsions of cholesteryl oleate and dimyristoylphosphatidylcholine: a model for cholesteryl ester rich very low density lipoproteins. (1986) (20)
Composition-structure-function correlations in the binding of an apolipoprotein to phosphatidylcholine bilayer mixtures. (1977) (18)
Pathophysiology and treatment of lipid perturbation after cardiac transplantation. (1997) (18)
Effect of lyso-phosphatidylcholine and Schnurri-3 on osteogenic transdifferentiation of vascular smooth muscle cells to calcifying vascular cells in 3D culture. (2013) (18)
Quantitative Segmentation of Principal Carotid Atherosclerotic Lesion Components by Feature Space Analysis Based on Multicontrast MRI at 1.5 T (2009) (18)
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. (1994) (18)
Differential Aortic and Mitral Valve Interstitial Cell Mineralization and the Induction of Mineralization by Lysophosphatidylcholine In Vitro (2014) (17)
Algorithm for quantifying advanced carotid artery atherosclerosis in humans using MRI and active contours (2002) (17)
Guinea pig brain acetylcholinesterase: partial purification by affinity chromatography. (1973) (17)
Metabolism of Apo(a) and ApoB-100 in Human Lipoprotein(a) (1993) (17)
Quantitation of lipid in biological tissue by chemical shift magnetic resonance imaging (1994) (17)
Lipoprotein-X: proton and phosphorus-31 nuclear magnetic resonance studies on native, reconstituted, and model systems. (1980) (16)
Interaction of apoliprotein C-III with phosphatidylcholine vesicles. Dependence of aproprotein-phospholipid complex formation on vesicle structure. (1977) (15)
Cholesterol metabolism in hypercholesterolemia-resistant rabbits. (1991) (14)
Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD) (2009) (14)
Biophysical properties of a major membrane phospholipid, dielaidoylphosphatidylethanolamine, found in an Escherichia coli fatty acid auxotroph. (1979) (14)
Lipoprotein‐X: a substrate for lecithin: cholesterol acyltransferase (1977) (14)
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. (2013) (14)
Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease (2016) (14)
13C NMR studies of the thermal properties of a model high density lipoprotein. Apolipoprotein A-I-dimyristoylphosphatidylcholine complex. (1984) (13)
The mechanism of lipid-binding by plasma lipoproteins (2005) (13)
Magnetic resonance studies of apolipoprotein C-I nitroxide labeled or [13C]methyl enriched at methionine-38. (1980) (13)
Identification of different lipid phases and calcium phosphate deposits in human carotid artery plaques by MAS NMR spectroscopy (1998) (13)
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. (2011) (12)
Time dependent changes in aortic tissue during cold storage in physiological solution. (2011) (12)
Identification and quantification of apolipoproteins in addition to apo[a] and apo B-100 in human lipoprotein[a]. (1994) (12)
Delivery of negatively charged liposomes into the atheromas of Watanabe heritable hyperlipidemic rabbits (2010) (12)
Amino acid sequence of rabbit apolipoprotein E. (1991) (11)
Classification Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles for Prostate Cancer (2006) (11)
Acrylodan can label amino as well as sulfhydryl groups: results with low-density lipoprotein, lipoprotein[a], and lipid-free proteins. (1993) (11)
Permeation of human plasma lipoproteins in human carotid endarterectomy tissues: measurement by optical coherence tomography (2011) (11)
Hyaluronan turnover and hypoxic brown adipocytic differentiation are co-localized with ossification in calcified human aortic valves. (2012) (11)
DYNAMICS OF LIPID MOTIONS IN HIGH‐DENSITY LIPOPROTEIN SUBFRACTIONS HDL2 AND HDL3: MAGNETIC RESONANCE STUDIES (1980) (11)
Human lysosomal sphingomyelinase: substrate efficacy of apolipoprotein/sphingomyelin complexes. (1986) (10)
Postprandial effects on arterial stiffness parameters in healthy young adults (2015) (10)
Vascular calcification in homozygote familial hypercholesterolemia. (2008) (9)
Lipolysis of phospholipids in model cholesteryl ester rich lipoproteins and related systems: effect of core and surface lipid phase state. (1988) (9)
Morphometric analysis of calcification and fibrous layer thickness in carotid endarterectomy tissues (2016) (9)
Interaction of human plasma apolipoproteins and phospholipids. Semi-quantitative studies using polyacrylamide gel electrophoresis. (1975) (9)
Distribution of calcification in carotid endarterectomy tissues: Comparison of micro-computed tomography imaging with histology (2014) (8)
THE USE OF SPIN LABELS FOR MEASURING DISTANCES IN BIOLOGICAL SYSTEMS * (1973) (8)
A review of the unique features of HDL apoproteins (1979) (7)
Spin-labeled ribonuclease. A. Selective incorporation of a nitroxide spin label sensitive to active-center geometry. (1973) (7)
Lipoprotein-X: carbon-13 nuclear magnetic resonance studies on native, reconstituted, and model systems. (1980) (7)
Motion and surface accessibility of spin-labeled lipids in a model lipoprotein containing cholesteryl oleate, dimyristoylphosphatidylcholine, and apolipoprotein E. (1986) (7)
Cholesterol metabolism in fibroblasts from rabbits resistant to diet-induced hypercholesterolemia. (1990) (7)
Quantification of Carotid Atherosclerotic Plaque Components using Feature Space Analysis and Magnetic Resonance Imaging (2006) (7)
Electron cryomicroscopy and digital image processing of lipoprotein(a). (1994) (7)
Patient-specific flow descriptors and normalised wall index in peripheral artery disease: a preliminary study (2018) (7)
An improved synthesis of methyl-labeled fatty acids (1976) (6)
The Primary Structure of Apolipoprotein-Serine * (2003) (6)
The interaction of apolipoprotein-alanine (apoC-III) with lipids: study of structural features required for binding. (1975) (5)
EFFECT OF SIROLIMUS ON PLASMA LIPID AND LIPOPROTEIN LEVELS AND METABOLISM IN RENAL TRANSPLANT PATIENTS (1999) (5)
Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy. (1994) (5)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study (2011) (5)
Molecular Association of Lipids and Proteins in the Plasma Lipoproteins: A Review (1976) (5)
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). (2016) (5)
Cyclopentanoid analogs of dipalmitoyl phosphatidic acid: effect of backbone geometry on thermotropic properties. (1990) (5)
Simultaneous bilateral magnetic resonance imaging of the femoral arteries in peripheral arterial disease patients (2011) (5)
Synthesis of carbon-13-labeled tetradecanoic acids. (1983) (5)
Estimation of carotid atherosclerotic plaque volume from in vivo magnetic resonance images (2002) (5)
Synthesis of saturated, unsaturated, spin-labeled, and fluorescent cholesteryl esters: Acylation of cholesterol using fatty acid anhydride and 4-pyrrolidinopyridine (1979) (5)
The conversion of phosphatidylethanolamine into phosphatidylcholine labeled in the choline group using methyl lodide, 18-crown-6 and potassium carbonate (1979) (5)
13C NMR spectroscopic analysis of phospholipid metabolism in adrenal chromaffin cells (1991) (4)
Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease. (2020) (4)
Carotid intima-media thickness in familial combined hyperlipidemia and LDL size. (2002) (4)
Book Review: Spin labeling in molecular biology. G. I. Likhtenshtein. Translated into English by P. S. Shelnitz. John Wiley and Sons, New York, 1976. 258 pages. $33.00 (1977) (4)
Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. (2016) (4)
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. (1991) (4)
The Ryanodine Receptor Contributes to the Lysophosphatidylcholine-Induced Mineralization in Valvular Interstitial Cells (2020) (3)
Proton NMR Basics (1995) (3)
OSTEOGENIC TRANSDIFFERENTIATION OF VASCULAR SMOOTH MUSCLE CELLS TO CALCIFYING VASCULAR CELLS IN 3D CULTURE: ENHANCEMENT BY LYSO-PHOSPHATIDYLCHOLINE AND ATTENUATION BY SCHNURRI-3 (2011) (3)
MPSA short communications (1988) (3)
Effects of saturated and polyunsaturated fat diets on the chemical and physical properties of lipoproteins from type V hyperlipoproteinemic subjects. (1980) (2)
Evaluating atherosclerotic lesions by magnetic resonance imaging: from dimensional to compositional quantitation. (2001) (2)
Direct observation of the distribution of fluorescent probes in phosphatidylcholine/cholesterol vesicles using flow microfluorometry. (1984) (2)
Electrophoretic methods for quantitation of lipoprotein [a]. (1996) (2)
A technique for flow-enhanced magnetic resonance angiography of the lower extremities. (1990) (2)
Quantitation and distribution of lipoprotein-associated phospholipase A(2) and oxidized low density lipoprotein in atherosclerotic lesions of carotid endarterectomy tissues (2006) (2)
Apolipoprotein C-III/sphingomyelin recombinants: formation, isolation, and characterization. (1986) (2)
Human Lp(a): regions in sequences of apoproteins similar to domains in signal transduction proteins. (1995) (2)
Interaction of LDL and Lp[a] with human skin fibroblasts. (1994) (2)
Detection of hydroxyapatite in calci fi ed cardiovascular tissues (2012) (2)
Differential proteome profile, biological pathways, and network relationships of osteogenic proteins in calcified human aortic valves (2021) (2)
Template‐based docking of a prolactin receptor proline‐rich motif octapeptide to FKBP12: Implications for cytokine receptor signaling (1997) (1)
Methods for studying lipid-protein interactions. (1973) (1)
CONFORMATIONAL STUDIES ON THE ACTIVE SITE OF ACETYLCHOLINESTERASE BY ELECTRON PARAMAGNETIC RESONANCE (1970) (1)
Image Fusion Technology (2014) (1)
Abstract: P252 LYSO-PHOSPHATIDYLCHOLINE INDUCES OSTEOGENIC GENE EXPRESSION AND PHENOTYPE IN VASCULAR SMOOTH MUSCLE CELLS (2009) (1)
Late Changes in Saphenous Vein Aorto-Coronary Bypass Grafts: Clinical, Angiographic, Lipid and Pathological Correlations (1990) (1)
Short-term Tracking of Atherosclerosis in Operated and Unoperated Human Carotid Arteries by High Resolution Magnetic Resonance Imaging (2007) (1)
Method for calculating 3-D coordinates from molecular stereograms (1992) (1)
Abstract 510: Morphometrics of Calcification in Carotid Endarterectomy Tissue (2013) (1)
Abstract 14405: Plaque Volume of Carotid Endarterectomy (CEA) Specimens Measured Using a Novel 3-Dimensional Ultrasound (3DUS) Technology (2011) (1)
Effect of Sirolimus Treatment on Gene Expression in Renal Transplant Patients (2007) (1)
Synthesis of spin-labeled neutral lipids: Nitroxyl derivatives of triglycerides and sterol esters (1974) (1)
Lipid—Protein Interactions in Human Plasma High Density Lipoproteins* (1974) (1)
Assessment of permeation of lipoproteins in human carotid tissue (2010) (1)
Detection of left atrial scar and changes of cardiac function in relation to AF ablation, by 3D late gadolinium enhancement (2014) (0)
Calf muscle perfusion maps from contrast-enhanced magnetic resonance imaging (CE-MRI) to assess peripheral arterial disease (2014) (0)
Noninvasive functional imaging of tissue abnormalities using optical coherence tomography (2010) (0)
Left atrial scar burden determined by delayed enhancement cardiac magnetic resonance at post radiofrequency ablation: association with atrial fibrillation recurrence (2012) (0)
Cholesteryl Ester-Rich Very Low Density Lipoproteins: Magnetic Resonance Studies (1980) (0)
Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease. (2022) (0)
Abstract 18: The Effect of Lipid Modification on Peripheral Arterial Disease after Endovascular Intervention Trial (ELIMIT) (2013) (0)
EVALUATION OF CALCIFICATION IN CAROTID ENDARTERECTOMY TISSUES WITH MICRO–COMPUTED TOMOGRAPHY IMAGING (2013) (0)
Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus. (2022) (0)
Abstract 17240: Differences in Longitudinal Trends in Skeletal Thigh Muscle Area Assessed With Magnetic Resonance Imaging Among Diabetic and Non-Diabetic Peripheral Artery Disease Patients (2017) (0)
Abstract 16715: Magnetic Resonance Imaging Based Arterial Signal Enhancement is Associated With Markers of Peripheral Artery Disease (2016) (0)
Lysophosphatidylcholine Alters Valvular Interstitial Cell Mineralization (2012) (0)
The Ryanodine Receptor Contributes to the Lysophosphatidylcholine-Induced Mineralization in Valvular Interstitial Cells (2020) (0)
Optical sensing of macromolecules and microparticles distribution in tissues (2012) (0)
Genetic susceptibility and resistance to diet-induced athero- sclerosis and hyperlipoproteinemia. I. Atherosclerosis. Abstr. (1981) (0)
Tracking changes in human carotid atherosclerosis using magnetic resonance imaging (2003) (0)
Abstract 4538: Poor Response to Aspirin in Patients with Peripheral Arterial Disease Enrolled in the Effect of Lipid Modification on Peripheral Arterial Disease after Endovascular Intervention Trial (ELIMIT) (2008) (0)
Assessment of leg muscle morphology by contrast-enhanced magnetic resonance imaging (CE-MRI) in patients with peripheral arterial disease (2013) (0)
Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease (2016) (0)
MRI VENOUS VOLUME MEASUREMENTS IN PERIPHERAL ARTERIAL DISEASE: A PILOT STUDY FROM THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION (ELIMIT) STUDY (2011) (0)
Optical coherence tomography in quantifying the permeation of human plasma lipoproteins in vascular tissues (2012) (0)
Assessment of Cardiovascular Disease Using Permeability Rates: Quantification by Optical Coherence Tomography (2013) (0)
CHANGES IN THIGH MUSCLE VOLUME OVER A ONE YEAR PERIOD IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD): A MAGNETIC RESONANCE IMAGING (MRI) ANALYSIS FROM THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION TRIAL (ELIMIT) (2010) (0)
Serum caveolin-1 discriminate between BPH and prostate cancer and is a prognostic marker for prostate cancer progression (2003) (0)
Abstract 16019: MRI Venous Volume Measurements are Associated With Ankle Brachial Index in Peripheral Artery Disease Patients: Results From the Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention Trial (ELIMIT) (2014) (0)
Bilateral Surface Coil for Lower Extremity Imaging at 3 T (2005) (0)
93191067 The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women (1994) (0)
The use of phospholipase-D in lipid chemistry. (1977) (0)
Magnetic Resonance Imaging‐Derived Microvascular Perfusion Modeling to Assess Peripheral Artery Disease (2023) (0)
Differential Aortic and Mitral Valve Interstitial Cell Mineralization and the Induction of Mineralization by Lysophosphatidylcholine In Vitro (2014) (0)
A STUDY OF LIPID-PROTEIN BINDING BY ELECTROPHORETIC LASER DOPPLER SPECTROSCOPY (1976) (0)
Is carotid artery atherosclerosis a bilaterally symmetrical disease (2002) (0)
1.W08.5 Formation and degradation of triglyceride rich-lipoprotein [a] (1997) (0)
ASSOCIATIONS BETWEEN LIPOPROTEIN CHOLESTEROL FRACTIONS AND MEASURES OF PLATELET AGGREGATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (2010) (0)
Effect of hypothermic preservation on biological tissues in physiological solution (2011) (0)
SAI-9: Quantitation of atherosclerotic plaque burden in the carotid arteries by magnetic resonance imaging (2001) (0)
Apo[a] phenotype and Lp[a] plasma concentrations in subjects with CAD or asymptomatic carotid atherosclerosis (MS190) (2002) (0)
SEGMENTAL ANALYSIS OF CIRCUMFERENTIAL SYSTOLIC CAROTID ARTERIAL STRAIN IN DIABETICS AND HYPERTENSIVES USING 2D SPECKLE TRACKING (2012) (0)
TWELVE MONTH PERSISTENCE OF POOR RESPONSE TO ASPIRIN IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE ENROLLED IN THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION TRIAL (ELIMIT) (2010) (0)
A Dual-Precipitation MethodEvaluated forMeasurement of Cholesterol in High-Density Lipoprotein Subfractions HDL2and HDL3in HumanPlasma (1989) (0)
Variability and Persistence of Poor Response to Aspirin by Aggregometry and PFA-100 over Twelve-Months in Peripheral Arterial Disease from the Effect of Lipid Modification on Peripheral Arterial Disease after Endovascular Intervention Trial (ELIMIT) (2011) (0)
Epidemiology and Prevention Associations Between Lipoprotein ( a ) Levels and Cardiovascular Outcomes in Black and White Subjects The Atherosclerosis Risk in Communities ( ARIC ) Study (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Joel D. Morrisett?

Joel D. Morrisett is affiliated with the following schools: